Optimized hybrid megavoltage-kilovoltage imaging protocol for volumetric prostate arc therapy.
OBJECTIVE
To develop a real-time prostate position monitoring technique for modern arc radiotherapy through novel use of cine-megavoltage (MV) imaging, together with as-needed kilovoltage (kV) imaging.


METHODS
We divided the task of monitoring the intrafraction prostate motion into two steps for rotational deliveries: to detect potential target motion beyond a predefined threshold using MV images from different viewing angles by taking advantage of gantry rotation during arc therapy and to verify the displacement and determine whether intervention is needed using fiducial/tumor position information acquired from combined MV-kV imaging (by turning on the kV imager). A Varian Trilogy linear accelerator with an onboard kV imager was used to examine selected typical trajectories using a four-dimensional motion phantom. The performance of the algorithm was evaluated using phantom measurements and computer simulation for 536 Calypso-measured tracks from 17 patients.


RESULTS
Fiducial displacement relative to the MV beam was limited to within a range of 3 mm 99.9% of the time with <1 mm accuracy. On average, only ∼0.5 intervention per arc delivery was needed to achieve this level of accuracy. Compared with other fluoroscopy-based tracking techniques, kV use was significantly reduced to an average of <15 times per arc delivery.


CONCLUSIONS
By focusing the attention on detecting predefined abnormal motion (i.e., "failure" detection) and using the inherent mechanism of gantry rotation during arc radiotherapy, the current approach provides high confidence regarding the prostate position in real time without the unwanted overhead of continuous or periodic kV imaging.
Liu
Wu
W
Department of Radiation Oncology, Stanford University School of Medicine, California 94305-5847, USA.
Wiersma
Rodney D
RD
Xing
Lei
L
D002933:Cineradiography / Q000379:methods; D019583:Dose Fractionation, Radiation; D006046:Gold; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000379:methods; D008297:Male; D009068:Movement; D011467:Prostate; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D019736:Prostheses and Implants; D011879:Radiotherapy Dosage; D050397:Radiotherapy, Intensity-Modulated / Q000379:methods*
D006046:Gold
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):419-25
17513059
Phys Med Biol. 2009 Jan 7;54(1):117-33
19075358
Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1117-23
12128110
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1084-90
18280057
Med Phys. 2008 Apr;35(4):1191-8
18491510
Med Phys. 2007 Oct;34(10):4041-63
17985650
Phys Med Biol. 2008 Sep 21;53(18):4959-70
18711242
Med Phys. 2009 Jun;36(6):2215-21
19610310
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):801-12
18234439
Semin Radiat Oncol. 2008 Jan;18(1):58-66
18082589
Phys Med Biol. 2008 Dec 21;53(24):7197-213
19043177
Phys Med Biol. 2008 Aug 21;53(16):4331-53
18660559
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):933-7
15708277
Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1088-98
17187940
Phys Med Biol. 2009 Jan 7;54(1):N9-20
19075362
Med Phys. 2008 Aug;35(8):3554-64
18777916